AstraZeneca PLC Director/PDMR Shareholding (5087U)
23 Noviembre 2023 - 9:00AM
UK Regulatory
TIDMAZN
RNS Number : 5087U
AstraZeneca PLC
23 November 2023
23 November 15:00 GMT
Transaction by Person Discharging Managerial
Responsibilities
AstraZeneca PLC (the Company) announces that, on 22 November, it
was notified of the following transactions in the Company's
ordinary shares of $0.25 each (Ordinary Shares) by Michel Demaré,
Non-Executive Chair of the Board.
PDMR Position Nature of Date Quantity Price
the transaction
Michel Demaré Non-Executive Purchase of 21/11/2023 1,000 GBGBP101.05
Chair of the Ordinary Shares
Board
-------------- ----------------- ----------- --------- -----------
Michel Demaré Non-Executive Purchase of 22/11/2023 1,000 GBGBP101.70
Chair of the Ordinary Shares
Board
-------------- ----------------- ----------- --------- -----------
Further details are set out in the attached notifications, made
in accordance with the requirements of the EU Market Abuse
Regulation (since it forms part of UK law pursuant to the European
Union (Withdrawal) Act 2018).
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Michel Demaré
--------------------------- --------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Non-Executive Chair of the Board
--------------------------- --------------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------- --------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name AstraZeneca PLC
--------------------------- --------------------------------------
b) LEI PY6ZZQWO2IZFZC3IOL08
--------------------------- --------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of US$0.25 each in
financial instrument, AstraZeneca PLC
type of instrument
Identification code GB0009895292
--------------------------- --------------------------------------
b) Nature of the transaction Purchase of AstraZeneca PLC Ordinary
Shares of US$0.25
--------------------------- --------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP101.05224 1,000
----------
--------------------------- --------------------------------------
d) Aggregated information Not applicable - single transaction
- Aggregated volume
- Price
--------------------------- --------------------------------------
e) Date of the transaction 21 November 2023
--------------------------- --------------------------------------
f) Place of the transaction LON
--------------------------- --------------------------------------
Details of the person discharging managerial responsibilities
1 / person closely associated
a) Name Michel Demaré
--------------------------- --------------------------------------
Reason for the notification
2
-------------------------------------------------------------------
a) Position/status Non-Executive Chair of the Board
--------------------------- --------------------------------------
b) Initial notification Initial notification
/Amendment
--------------------------- --------------------------------------
Details of the issuer, emission allowance market participant,
3 auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name AstraZeneca PLC
--------------------------- --------------------------------------
b) LEI PY6ZZQWO2IZFZC3IOL08
--------------------------- --------------------------------------
Details of the transaction(s): section to be repeated
4 for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of US$0.25 each in
financial instrument, AstraZeneca PLC
type of instrument
Identification code GB0009895292
--------------------------- --------------------------------------
b) Nature of the transaction Purchase of AstraZeneca PLC Ordinary
Shares of US$0.25
--------------------------- --------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
GBP101.70 1,000
----------
--------------------------- --------------------------------------
d) Aggregated information Not applicable - single transaction
- Aggregated volume
- Price
--------------------------- --------------------------------------
e) Date of the transaction 22 November 2023
--------------------------- --------------------------------------
f) Place of the transaction LON
--------------------------- --------------------------------------
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led
biopharmaceutical company that focuses on the discovery,
development, and commercialisation of prescription medicines in
Oncology, Rare Diseases, and BioPharmaceuticals, including
Cardiovascular, Renal & Metabolism, and Respiratory &
Immunology. Based in Cambridge, UK, AstraZeneca operates in over
100 countries and its innovative medicines are used by millions of
patients worldwide. Please visit astrazeneca.com and follow the
Company on Twitter @AstraZeneca .
Contacts
For details on how to contact the Investor Relations Team,
please click here . For Media contacts, click here .
Adrian Kemp
Company Secretary
AstraZeneca PLC
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHUORSROSUAUAA
(END) Dow Jones Newswires
November 23, 2023 10:00 ET (15:00 GMT)
Astrazeneca (LSE:0A4J)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Astrazeneca (LSE:0A4J)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
